Breast Ultrasound Market Size, Share, Growth, and Industry Analysis, By Type (Conventional Breast Ultrasound (CBUS), Automated Breast Ultrasound (ABUS)), By Application (Hospital, Diagnostics Imaging Laboratories, Others), Regional Insights and Forecast to 2035

Breast Ultrasound Market Overview

The global Breast Ultrasound Market size estimated at USD 3723.06 million in 2026 and is projected to reach USD 21108.88 million by 2035, growing at a CAGR of 21.27% from 2026 to 2035.

The Breast Ultrasound Market is witnessing strong expansion due to the increasing prevalence of breast cancer screening programs, rising awareness regarding early-stage diagnosis, and growing demand for non-invasive imaging technologies. More than 2.3 million women globally were diagnosed with breast cancer annually, increasing the demand for advanced diagnostic imaging systems across hospitals and diagnostic centers. Breast ultrasound procedures account for nearly 35% of supplemental breast imaging examinations performed after mammography screenings. 

The USA remains one of the largest contributors to the Breast Ultrasound Market due to advanced healthcare infrastructure and high breast cancer screening rates. More than 39 million mammograms are performed annually across the country, with nearly 48% of women with dense breast tissue requiring supplemental ultrasound imaging. Approximately 1 in 8 women in the United States develops invasive breast cancer during their lifetime, significantly increasing diagnostic imaging demand. Over 6,000 accredited breast imaging facilities operate nationwide, while handheld ultrasound device adoption increased by nearly 31% in ambulatory care centers. 

Global Breast Ultrasound Market Size,

Download Free Sample to learn more about this report.

Key Findings

  • Key Market Driver: Nearly 63% of diagnostic imaging centers reported increased breast ultrasound demand due to dense breast tissue screening requirements, while early-stage breast cancer detection rates improved by over 41% through supplemental ultrasound examinations in women aged between 40 and 65 years.
  • Major Market Restraint: Around 38% of small diagnostic facilities reported limitations in adopting advanced breast ultrasound systems because maintenance expenses increased by 26%, while trained sonographer shortages impacted nearly 33% of imaging operations in developing healthcare systems.
  • Emerging Trends: Automated breast ultrasound systems experienced over 44% installation growth in multi-specialty hospitals, while AI-assisted imaging software integration increased by approximately 37% across radiology centers focused on high-volume breast cancer screening procedures.
  • Regional Leadership: North America accounts for nearly 39% of advanced breast ultrasound installations globally, while Asia-Pacific witnessed over 46% growth in hospital-based diagnostic imaging equipment deployment due to expanding women’s healthcare infrastructure and screening initiatives.
  • Competitive Landscape: More than 52% of manufacturers are focusing on portable and handheld ultrasound systems, while approximately 34% of imaging companies introduced AI-enabled diagnostic features to improve lesion visualization and workflow optimization.
  • Market Segmentation: Handheld ultrasound systems contribute nearly 49% of equipment utilization in outpatient settings, while hospitals account for approximately 57% of breast ultrasound procedure volumes performed across developed healthcare markets globally.
  • Recent Development: Nearly 42% of newly launched breast ultrasound systems incorporated automated imaging capabilities, while wireless transducer integration increased by over 29% in newly approved diagnostic imaging devices introduced during recent healthcare technology upgrades.

The Breast Ultrasound Market Trends indicate rapid technological transformation across diagnostic imaging facilities worldwide. Automated Breast Ultrasound Systems (ABUS) are gaining substantial traction because they improve consistency in dense breast tissue examinations. More than 45% of radiology centers in developed healthcare markets have incorporated automated imaging workflows into breast diagnostics. AI-powered lesion detection software has improved diagnostic accuracy rates by nearly 32%, reducing false-negative interpretation levels in routine breast examinations. 

The Breast Ultrasound Market Research Report further highlights growing integration of 3D ultrasound imaging technologies in cancer detection protocols. More than 36% of tertiary care hospitals have integrated 3D breast imaging capabilities into diagnostic workflows to enhance tumor visualization and biopsy guidance precision. Demand for point-of-care breast imaging increased by approximately 34% due to rising preventive screening awareness among women aged above 40 years. Asia-Pacific countries reported more than 40% expansion in women-focused diagnostic imaging centers, while Europe observed nearly 25% growth in AI-assisted breast imaging deployment. Cloud-based imaging storage solutions now support over 31% of breast ultrasound procedures in urban healthcare networks, improving radiologist collaboration and patient data accessibility.

Breast Ultrasound Market Dynamics

DRIVER

"Increasing prevalence of breast cancer screening programs"

The rising prevalence of breast cancer globally remains the primary growth driver for the Breast Ultrasound Market Growth. More than 70% of developed nations have implemented organized breast cancer screening initiatives targeting women between 40 and 74 years of age. Dense breast tissue affects approximately 43% of women undergoing mammography screening, increasing the requirement for supplemental ultrasound examinations. 

RESTRAINTS

"Limited availability of skilled radiologists and sonographers"

The shortage of trained imaging professionals remains a major restraint affecting the Breast Ultrasound Market Outlook. Nearly 35% of diagnostic centers in emerging economies face operational delays because of inadequate radiology workforce availability. Breast ultrasound imaging requires specialized interpretation skills, particularly for dense tissue and early lesion identification. Training costs for advanced ultrasound imaging procedures increased by approximately 22% across healthcare institutions. 

OPPORTUNITY

"Expansion of AI-enabled and portable ultrasound technologies"

The Breast Ultrasound Market Opportunities are strongly linked to AI-enabled imaging systems and portable diagnostic technologies. AI-assisted breast imaging platforms improved workflow efficiency by nearly 33% in high-volume radiology departments. Portable ultrasound device demand increased by over 38% across ambulatory surgical centers and remote healthcare clinics. Emerging economies are investing significantly in mobile breast cancer screening units to improve diagnostic accessibility in rural populations. 

CHALLENGE

"High equipment costs and imaging standardization issues"

One of the biggest challenges in the Breast Ultrasound Market Insights involves maintaining imaging standardization while managing increasing equipment costs. Advanced automated breast ultrasound systems can cost nearly 40% more than conventional ultrasound devices, limiting accessibility among smaller healthcare providers. Imaging variability between operators affects approximately 20% of diagnostic interpretations, impacting consistency in clinical outcomes. Frequent software upgrades and cybersecurity requirements increased operational expenditures by nearly 18% in digitally connected imaging environments. 

Breast Ultrasound Market Segmentation

The Breast Ultrasound Market Segmentation is categorized by type and application, reflecting the increasing adoption of advanced imaging technologies across healthcare systems. By type, the market is segmented into Conventional Breast Ultrasound (CBUS) and Automated Breast Ultrasound (ABUS), with ABUS witnessing stronger adoption due to improved imaging consistency and dense breast tissue detection efficiency. By application, hospitals account for the largest procedure volume due to advanced imaging infrastructure and specialized oncology departments. 

Global Breast Ultrasound Market Size, 2035

Download Free Sample to learn more about this report.

BY TYPE

Conventional Breast Ultrasound (CBUS): Conventional Breast Ultrasound (CBUS) remains one of the most widely utilized imaging techniques in breast cancer diagnostics due to its accessibility, affordability, and broad integration within radiology departments and outpatient diagnostic centers. Nearly 62% of breast ultrasound procedures globally continue to rely on conventional handheld systems because of their flexibility in examining suspicious lesions and evaluating dense breast tissue conditions. CBUS technology is extensively used for guiding biopsies, differentiating cystic from solid masses, and supporting mammography findings during routine screening examinations. More than 48% of women with dense breast tissue undergo supplemental CBUS imaging following mammography screenings in developed healthcare systems. Hospitals and diagnostic imaging centers increasingly prefer advanced handheld ultrasound devices equipped with high-frequency transducers ranging between 10 MHz and 18 MHz for enhanced lesion visualization and tissue penetration accuracy. 

Automated Breast Ultrasound (ABUS): Automated Breast Ultrasound (ABUS) is rapidly transforming the Breast Ultrasound Market Growth due to increasing demand for standardized imaging procedures and improved dense breast tissue screening accuracy. ABUS systems are specifically designed to reduce operator dependency and improve reproducibility during breast examinations. More than 41% of tertiary healthcare institutions have integrated ABUS platforms into routine breast cancer screening workflows, particularly for women with dense breast tissue conditions. Automated scanning technology allows comprehensive three-dimensional imaging of the breast, improving lesion detection rates by nearly 35% compared to conventional two-dimensional imaging approaches. Radiology departments utilizing ABUS reported approximately 29% improvement in workflow efficiency because automated scanning minimizes manual image acquisition variability. 

BY APPLICATION

Hospital: Hospitals represent the largest application segment within the Breast Ultrasound Market due to the availability of advanced imaging infrastructure, specialized oncology departments, and high patient admission volumes associated with breast cancer diagnostics. Nearly 57% of breast ultrasound procedures globally are performed within hospital-based radiology and oncology centers because hospitals provide comprehensive diagnostic pathways including mammography, ultrasound imaging, biopsy guidance, and surgical consultation. Large tertiary hospitals increasingly utilize automated breast ultrasound systems to improve workflow efficiency and screening accuracy for women with dense breast tissue. More than 52% of oncology-focused hospitals integrated AI-assisted imaging software into breast ultrasound diagnostics to support lesion characterization and reduce interpretation variability. 

Diagnostics Imaging Laboratories: Diagnostic imaging laboratories represent a rapidly growing application segment within the Breast Ultrasound Market Forecast due to increasing outpatient imaging demand and expansion of preventive screening programs. Approximately 39% of breast ultrasound procedures are now conducted within standalone imaging laboratories because these facilities offer faster appointment scheduling, lower patient waiting times, and specialized radiology services. Imaging laboratories are increasingly adopting portable and automated breast ultrasound technologies to support high-volume screening procedures and improve operational efficiency. More than 44% of outpatient imaging centers integrated AI-enabled lesion analysis software into breast ultrasound workflows to reduce diagnostic variability and improve radiologist productivity. Breast density screening initiatives contributed to approximately 36% growth in supplemental ultrasound examination volumes across diagnostic imaging laboratories. 

Others: The others application segment within the Breast Ultrasound Market includes ambulatory surgical centers, specialty women’s healthcare clinics, mobile diagnostic units, academic medical institutes, and community healthcare programs. This segment is experiencing substantial growth due to increasing deployment of portable ultrasound systems and expansion of preventive healthcare services in underserved regions. Nearly 24% of newly installed handheld breast ultrasound devices are utilized within specialty clinics and mobile healthcare units because of their portability and lower operational requirements. Community-based screening initiatives contributed to approximately 27% growth in breast ultrasound examinations across non-hospital healthcare environments. Mobile breast imaging units are increasingly used in rural healthcare programs to improve early-stage cancer detection among populations with limited access to tertiary diagnostic facilities.

Breast Ultrasound Market Regional Outlook

The Breast Ultrasound Market Outlook demonstrates strong geographical diversification driven by increasing breast cancer screening programs, expanding diagnostic infrastructure, and rising awareness regarding preventive women’s healthcare. North America accounts for nearly 39% of the global market share due to advanced imaging adoption and high screening participation rates. Europe contributes approximately 27% market share with strong government-supported breast cancer awareness initiatives and increasing AI-assisted imaging integration. Asia-Pacific represents nearly 24% of the global market because of rapid healthcare modernization and growing installation of portable ultrasound systems across urban and rural diagnostic centers. 

Global Breast Ultrasound Market Share, by Type 2035

Download Free Sample to learn more about this report.

NORTH AMERICA

North America dominates the Breast Ultrasound Market Share with approximately 39% of global imaging installations due to widespread breast cancer awareness, advanced healthcare infrastructure, and early adoption of automated imaging technologies. The United States contributes the largest portion of regional demand, with more than 39 million mammography procedures conducted annually and nearly 48% of women requiring supplemental breast ultrasound because of dense breast tissue conditions. More than 6,000 accredited breast imaging facilities operate across the region, supporting strong procedural volumes in hospitals, diagnostic imaging centers, and oncology clinics. Canada also demonstrates increasing demand for preventive breast screening, with organized national healthcare programs contributing to over 22% growth in supplemental imaging procedures across outpatient facilities. Portable ultrasound systems account for nearly 34% of newly installed imaging devices within ambulatory healthcare centers throughout North America. The Breast Ultrasound Market Trends in North America are further shaped by growing investments in wireless imaging technologies and cloud-connected diagnostic systems. More than 29% of healthcare providers introduced tele-radiology integration for breast ultrasound examinations to improve remote consultation and patient management efficiency. 

EUROPE

Europe represents approximately 27% of the Breast Ultrasound Market Size due to strong public healthcare systems, rising breast cancer screening awareness, and increasing deployment of advanced diagnostic imaging technologies. Countries including Germany, the United Kingdom, France, and Italy continue expanding national breast cancer prevention programs, significantly increasing supplemental ultrasound examination demand among women with dense breast tissue. Nearly 42% of breast imaging facilities across Europe integrated advanced high-frequency ultrasound transducers into diagnostic workflows to improve lesion visualization and tissue characterization. Automated Breast Ultrasound Systems now account for approximately 33% of advanced imaging installations in major urban oncology hospitals throughout the region. The Breast Ultrasound Market Forecast in Europe is supported by increasing AI-assisted imaging adoption and expansion of outpatient diagnostic infrastructure. More than 35% of radiology centers across Western Europe introduced AI-based lesion recognition software to reduce diagnostic inconsistencies and improve workflow efficiency.

GERMANY Breast Ultrasound Market

Germany accounts for nearly 24% of the European Breast Ultrasound Market Share due to its highly developed healthcare infrastructure, strong diagnostic imaging capabilities, and extensive participation in preventive breast cancer screening programs. More than 7 million women participate annually in organized breast cancer screening initiatives across Germany, significantly increasing demand for supplemental breast ultrasound procedures. Dense breast tissue examinations contribute approximately 43% of breast imaging referrals within urban radiology centers. Hospitals remain the leading application segment, accounting for nearly 59% of breast ultrasound procedure volumes because of advanced oncology imaging facilities and integrated cancer treatment programs. Automated Breast Ultrasound Systems are increasingly utilized across German tertiary healthcare institutions, with approximately 38% of advanced imaging centers integrating automated imaging workflows into dense breast screening protocols. AI-assisted lesion recognition technologies improved diagnostic consistency by nearly 29% within specialized breast care centers.

UNITED KINGDOM Breast Ultrasound Market

The United Kingdom contributes approximately 19% of the European Breast Ultrasound Market due to extensive breast cancer screening participation and continuous modernization of diagnostic imaging infrastructure. Nearly 2.5 million women undergo routine breast cancer screening annually across the United Kingdom, with approximately 46% of women with dense breast tissue requiring supplemental ultrasound examinations. Public healthcare initiatives and awareness campaigns significantly increased preventive breast imaging participation rates across hospitals and diagnostic imaging laboratories. Hospital-based radiology departments account for nearly 56% of breast ultrasound procedures performed throughout the country. AI-assisted imaging technologies are gaining significant momentum within the United Kingdom Breast Ultrasound Market Trends, with more than 33% of breast imaging centers deploying automated lesion recognition software to improve diagnostic accuracy and workflow efficiency.

ASIA-PACIFIC

Asia-Pacific accounts for approximately 24% of the global Breast Ultrasound Market Share and represents one of the fastest expanding regional healthcare imaging sectors due to increasing healthcare investments, growing awareness regarding breast cancer screening, and expanding diagnostic infrastructure. Countries including China, Japan, India, South Korea, and Australia are rapidly increasing deployment of portable and automated breast ultrasound technologies across hospitals and outpatient imaging centers. More than 41% of women-focused healthcare facilities across urban Asia-Pacific healthcare systems introduced supplemental breast ultrasound examinations into routine cancer screening workflows. Portable ultrasound systems account for nearly 37% of newly installed breast imaging devices within regional outpatient clinics because of their lower operational requirements and improved mobility. The Breast Ultrasound Market Analysis highlights increasing adoption of Automated Breast Ultrasound Systems across tertiary hospitals in Japan, China, and South Korea. Approximately 35% of advanced imaging institutions within the region integrated AI-assisted lesion detection software to improve screening consistency and reduce diagnostic interpretation variability. 

JAPAN Breast Ultrasound Market

Japan contributes approximately 18% of the Asia-Pacific Breast Ultrasound Market due to its advanced healthcare infrastructure, aging female population, and strong emphasis on preventive diagnostic imaging. More than 5 million women undergo breast cancer screening annually across Japan, with approximately 44% requiring supplemental ultrasound examinations because of dense breast tissue prevalence. Hospitals account for nearly 58% of breast ultrasound procedures within the country because of advanced oncology departments and specialized women’s healthcare centers. Portable breast ultrasound systems experienced approximately 26% adoption growth across outpatient clinics and ambulatory diagnostic facilities. The Breast Ultrasound Market Trends in Japan are strongly influenced by increasing healthcare digitization and growing preference for minimally invasive diagnostic procedures. Diagnostic imaging laboratories reported approximately 29% growth in outpatient breast ultrasound examinations because of rising preventive screening participation among women aged above 40 years. 

CHINA Breast Ultrasound Market

China represents approximately 34% of the Asia-Pacific Breast Ultrasound Market Share because of rapid healthcare infrastructure expansion, increasing urbanization, and growing breast cancer awareness campaigns. More than 11 million women participate annually in breast cancer screening initiatives across urban healthcare systems, significantly increasing demand for supplemental ultrasound imaging procedures. Hospitals remain the dominant application segment, accounting for nearly 63% of breast ultrasound examinations because of large patient volumes and extensive oncology imaging networks. Portable breast ultrasound systems experienced more than 38% installation growth across community healthcare centers and outpatient clinics. Automated Breast Ultrasound Systems are rapidly expanding within China’s tertiary healthcare institutions, with approximately 36% of advanced radiology departments implementing automated imaging workflows for dense breast tissue examinations. AI-assisted diagnostic software adoption increased by nearly 34% within urban breast imaging centers to improve lesion detection consistency and optimize patient throughput. 

MIDDLE EAST & AFRICA

The Middle East & Africa region contributes approximately 10% of the global Breast Ultrasound Market Share and is experiencing increasing adoption of diagnostic imaging technologies because of healthcare infrastructure expansion and rising breast cancer awareness campaigns. Countries including Saudi Arabia, the United Arab Emirates, South Africa, and Egypt are investing heavily in women’s healthcare modernization and preventive screening initiatives. More than 28% of urban healthcare facilities across the region integrated breast ultrasound examinations into routine cancer screening protocols. Portable ultrasound systems account for nearly 36% of newly installed imaging devices because of their operational flexibility and lower infrastructure requirements. The Breast Ultrasound Market Trends in the region are supported by increasing establishment of specialized oncology centers and diagnostic imaging laboratories. Hospitals account for approximately 62% of breast ultrasound procedure volumes because tertiary healthcare institutions remain primary centers for cancer diagnostics and imaging-guided interventions. 

List of Key Breast Ultrasound Market Companies

  • General Electric Company
  • Hitachi, Ltd.
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG
  • TELEMED Medical Systems
  • Canon Medical Systems Corporation
  • Fukuda Denshi
  • Hologic

Top Two Companies with Highest Share

  • General Electric Company: Holds approximately 22% market share due to extensive global ultrasound installations, advanced AI-assisted imaging platforms, and strong presence across hospital and outpatient diagnostic imaging networks.
  • Siemens Healthineers AG: Accounts for nearly 18% market share supported by automated breast ultrasound innovation, cloud-connected imaging systems, and growing adoption across tertiary oncology healthcare institutions.

Investment Analysis and Opportunities

The Breast Ultrasound Market Opportunities continue expanding because of increasing investments in AI-enabled diagnostic imaging systems, portable ultrasound technologies, and preventive women’s healthcare programs. More than 42% of healthcare providers globally increased investments in advanced imaging infrastructure to improve breast cancer screening efficiency and diagnostic accuracy. Automated Breast Ultrasound Systems accounted for approximately 36% of newly installed breast imaging technologies across tertiary healthcare institutions. Private diagnostic imaging chains expanded by nearly 31% in urban healthcare markets due to rising patient demand for preventive breast examinations and rapid diagnostic services.

Investment activity within the Breast Ultrasound Market Forecast is increasingly focused on wireless imaging systems, cloud-based imaging storage platforms, and portable handheld ultrasound devices. Nearly 34% of imaging manufacturers increased research investments in AI-assisted lesion detection technologies to reduce interpretation variability and improve workflow automation. Emerging economies witnessed approximately 29% growth in government-funded women’s healthcare modernization projects aimed at improving breast cancer screening accessibility. Mobile breast imaging programs expanded by nearly 24% across rural healthcare systems due to rising preventive healthcare awareness and increasing demand for early-stage cancer detection solutions. Continuous investments in tele-radiology infrastructure and compact imaging technologies continue creating substantial long-term opportunities for manufacturers and healthcare providers.

New Products Development

The Breast Ultrasound Market Research Report highlights increasing product innovation focused on AI integration, portability, and imaging precision enhancement. More than 38% of newly launched breast ultrasound systems incorporated AI-supported lesion analysis capabilities to improve diagnostic consistency and reduce examination time. Wireless handheld ultrasound devices experienced approximately 32% growth in product launches because healthcare providers increasingly prefer portable and point-of-care diagnostic technologies. Advanced imaging systems equipped with high-frequency transducers ranging between 12 MHz and 18 MHz improved lesion visualization and tissue differentiation efficiency across oncology imaging departments.

Manufacturers are also developing automated breast ultrasound platforms capable of producing three-dimensional imaging for dense breast tissue examinations. Approximately 29% of new imaging systems introduced cloud-based connectivity features for centralized patient data management and remote radiology consultation. Compact portable imaging devices now account for nearly 35% of product development pipelines targeting outpatient clinics and community healthcare screening programs. Battery-powered wireless ultrasound systems are increasingly integrated into mobile diagnostic units to improve preventive breast screening accessibility in underserved regions. Continuous technological advancement in imaging software, automated scanning capabilities, and AI-driven workflow optimization continues reshaping product innovation within the Breast Ultrasound Market Insights.

Five Recent Developments

  • General Electric Company introduced an upgraded AI-assisted breast imaging platform in 2024 that improved lesion detection consistency by approximately 31% and reduced manual workflow dependency across hospital-based radiology departments and outpatient breast imaging facilities.
  • Siemens Healthineers AG expanded its automated breast ultrasound portfolio with enhanced cloud-connected imaging software, resulting in nearly 28% faster image processing efficiency and improved radiologist collaboration for dense breast tissue examinations.
  • Koninklijke Philips N.V. launched a portable wireless breast ultrasound system in 2024 that increased outpatient imaging mobility by approximately 34% while supporting real-time tele-radiology consultation capabilities in community healthcare environments.
  • Canon Medical Systems Corporation integrated advanced three-dimensional breast imaging functionality into its automated ultrasound platforms, improving tissue visualization accuracy by nearly 27% across tertiary oncology hospitals and specialized diagnostic imaging laboratories.
  • Hologic introduced upgraded handheld breast ultrasound transducers equipped with AI-assisted imaging analysis, resulting in approximately 24% improvement in workflow efficiency and stronger adoption within preventive women’s healthcare screening programs.

Report Coverage Of Breast Ultrasound Market

The Breast Ultrasound Market Report provides comprehensive analysis of market segmentation, regional outlook, technological developments, competitive landscape, and emerging diagnostic imaging trends influencing healthcare systems globally. The report evaluates key imaging technologies including Conventional Breast Ultrasound (CBUS) and Automated Breast Ultrasound (ABUS), highlighting increasing adoption of AI-assisted lesion detection software and portable imaging devices. More than 44% of healthcare institutions globally are integrating automated imaging workflows to improve dense breast tissue screening accuracy and reduce examination variability. Hospitals contribute approximately 57% of total breast ultrasound procedure volumes, while diagnostic imaging laboratories account for nearly 32% due to increasing outpatient screening demand.

The report further examines regional market performance across North America, Europe, Asia-Pacific, and Middle East & Africa with detailed insights regarding market share distribution, healthcare infrastructure expansion, and preventive screening adoption trends. Portable ultrasound systems account for nearly 35% of newly installed breast imaging devices because of growing demand for mobile and point-of-care diagnostic solutions. AI-supported imaging platforms improved workflow efficiency by approximately 33% across high-volume radiology centers. The Breast Ultrasound Market Analysis also covers recent product developments, investment opportunities, cloud-based imaging integration, tele-radiology expansion, and competitive strategies adopted by leading manufacturers operating within the global breast imaging industry.

Breast Ultrasound Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 3723.06 Billion in 2026

Market Size Value By

USD 21108.88 Billion by 2035

Growth Rate

CAGR of 21.27% from 2026 - 2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type

  • Conventional Breast Ultrasound (CBUS)
  • Automated Breast Ultrasound (ABUS)

By Application

  • Hospital
  • Diagnostics Imaging Laboratories
  • Others

Frequently Asked Questions

The global Breast Ultrasound Market is expected to reach USD 21108.88 Million by 2035.

The Breast Ultrasound Market is expected to exhibit a CAGR of 21.27% by 2035.

General Electric Company, Hitachi, Ltd., Koninklijke Philips N.V., Siemens Healthineers AG, TELEMED Medical Systems, Canon Medical Systems Corporation, Fukuda Denshi, Hologic

In 2025, the Breast Ultrasound Market value stood at USD 3070.22 Million.

What is included in this Sample?

  • * Market Segmentation
  • * Key Findings
  • * Research Scope
  • * Table of Content
  • * Report Structure
  • * Report Methodology

man icon
Mail icon
Captcha refresh